In Shakespeare’s time, medicine was based on the Hippocratic theory of the four bodily humors, or fluids. Good health was all about keeping these humors in balance, and it was understood that everyone was different. In a sense, today’s individualized medical approaches are cycling back to the understanding that we’re all unique. Hepatobiliary tumors — abnormal growths of the liver, gallbladder and bile ducts — are a leading cause of cancer worldwide, according to the American Cancer Society. But distinctive information about each patient and tumor can make all the difference.
Across the U.S., the National Cancer Institute supports more than 60 Specialized Programs of Research Excellence (SPOREs), each focusing on a specific group of related cancers. SPORE grants are like rocket fuel for translational cancer research, helping findings move quickly from the basic science laboratory to patient care. Understanding the need for that kind of propellant behind hepatobiliary tumor research, gastroenterology researchers Mark McNiven, Ph.D., and Lewis R. Roberts, M.B., Ch.B., Ph.D., successfully brought a hepatobiliary SPORE to Mayo Clinic and now act as principal investigators for the new program. Read the rest of the article on Discovery's Edge.
Other Mayo Clinic medical research websites: